Vertical Marketplace Go-to-Market in Regulated Industries

Medical groups using off-the-shelf SaaS platforms channel a substantial slice of their subscription spending into retrofitting regulatory fixes and bolted-on adjustments. Carriers forcing broad-purpose software into niche insurance processes consistently cite significant efficiency losses from the extra labor involved. Such costs extend well beyond initial setup. The flaw is structural: tools built for general audiences presume data stays in-house, yet no configuration menu can fix that when regulators, examiners, or external lawyers require access.

Once that expense is behind them, their next purchase looks different. They seek solutions where regulatory adherence comes built in rather than requiring their own teams to manage it as a separate initiative. This altered outlook explains why specialized, regulation-first systems now earn consideration in sourcing discussions where broad vendors relying solely on flexibility fall short.

Horizontal incumbents recognize the risk and are building AI directly into their platforms, including Salesforce Agentforce, ServiceNow Now Assist, Microsoft Copilot, the Gemini Enterprise Agent Platform from Google, plus the plugin layer from OpenAI, pushing broad systems further inside enterprise work. Configuration can add depth, but it cannot equal compliance rooted in the product itself, a distinction familiar to buyers who already paid for the first kind.

Compliance Architecture as the GTM Forcing Function

For regulated buyers, a platform is viable only when compliance is embedded in its architecture from day one, and that is where a vertical marketplace’s go-to-market motion has to begin. Compliance defines the whole motion: why a buyer agrees to the first meeting, why they sign, and what keeps them around, rather than an issue left for legal near the end of the deal.

Purchasers across medical, coverage, and law sectors scrutinize a vendor just as they would any entity that might appear in their upcoming compliance review. Embedding regulatory adherence directly into daily processes rather than burying it inside setup options reshapes the entire purchasing dialogue. The sale stops trying to match horizontal tools on feature parity and instead demonstrates the degree of operational exposure it eliminates for the client.

Harvey shows this dynamic more clearly than any other example. Its compliance work created the opening, and after that, the AI capability won the deal.

Retention implication follows from the identical underlying cause. Pricing works the same way: buyers in regulated industries can attach a dollar figure to what a botched audit or open compliance issue would cost them, which makes the worth of eliminating that risk something they can justify and defend when negotiating, far more than any vague efficiency pitch ever could be.

Compliance Architecture and ICP Selection

For regulated verticals, build the ideal customer profile from the buyer’s compliance readiness and the regulatory burden on its workflows, not from headcount, SIC/NAICS category, or revenue tier. Targeting the wrong slice of a promising vertical can leave deals trapped in procurement, since the buyer's approval process is not set up to move fast for this type of product.

No other software sector endures longer enterprise sales cycles than regulated industries. Large-scale deals in Fintech and similarly governed sectors can stretch beyond a year or last several months, since transactions touching customer money, private information, or reporting systems demand clearance from IT security, compliance, risk, and legal teams prior to closing. Picking a vertical means picking a cycle length. A GTM leader who chooses one without factoring in that cycle length sets revenue targets the business has no realistic path to hit.

In a regulated vertical, the right ICP screen is not just a “large regulated company,” but the customer facing enough compliance pressure to pay for a solution now. By 2026, investors were reading the opportunity similarly: choose law, healthcare, finance, or industry, validate control over vertical-specific data and workflows, and layer enterprise distribution on top. Veeva’s life-sciences foothold illustrates the filter in practice: instead of pursuing the whole market, it centered on customers whose regulatory record-keeping pain dominated operations, and that choice defined the company’s path afterward.

The beachhead sales motion: why narrow credibility wins enterprise trust faster than broad capability

After compliance readiness replaces firmographics as the ICP criterion, the selling effort must narrow instead of widen. In a regulated vertical, the strongest play is to concentrate on a narrow, highly credible slice of the ICP, then allow the regulatory and peer confidence built there to compress everything downstream in the funnel. Sweeping capability assertions become burdens in compliance-driven buying, not advantages, since such buyers seek grounds to reject, not to admire.

Harvey's initial fifty enterprise clients all arrived via referrals from law firms already on the platform. The company kept its GTM logic deliberately tight instead of sprawling: it concentrated on the hundred biggest law firms, presented itself not as a generic tool but as a digital associate, and that wedge approach turned Am Law 100 adoption into the trust signal that unlocked each new conversation.

The same idea generalizes beyond legal. In life sciences, Veeva gained access through its FDA tie, much as Harvey benefited from law firm referrals in legal: buyers hear a different story from a platform backed by a regulator or outside certification than from a vendor asking them to trust its compliance claims. Starting small means fewer opportunities, but the wins come through and then feed referrals that outpace any broad pipeline stuck in place. This deal-by-deal proof within a trusted segment creates the reference base needed to defend the next choice: pricing.

Compliance Architecture and Pricing Structure

Access is the organizing logic for per-seat and tiered-feature models: the number of users, the modules they get, and the tier of features included. This logic clashes with regulated buyers’ value calculus, because they are paying to lower risk, not to add seats. In these markets, vendors driving the greatest expansion revenue now tie pricing to the scale of each buyer’s regulatory exposure.

nCino's adoption of pricing tied to assets, a rollout that began in fiscal 2025, stands as the most obvious case. In this arrangement, what current clients pay in recurring fees rises alongside their asset books and how much of the platform's AI tools they actually use, not according to how many employee logins the institution maintains. This setup ties what a bank pays straight to the compliance exposure the system handles for it, so institutions with bigger loan books face more oversight territory and see their charges rise in step, no contract renegotiation needed.

Tying charges to results or usage also addresses a separate hurdle for regulated buyers: getting purchases approved. A contract that bills only as compliance work is cleared tends to win legal and risk approval faster than locking in seats for several years upfront, since reviewers inside the buyer are asked to bless limited, easier-to-understand risk increments along the way. In fiscal 2026, two top-50 lenders in the U.S. market, each above the $50 billion asset mark, raised their commitments to nCino’s commercial lending platform by over 30% and 60%, respectively. That expansion came from growth in the banks' own asset portfolio, not from an upsell push nCino needed to run.

The Compliance Moat and Land-and-Expand

That same compliance architecture pulls buyers in, sets pricing, and opens the door to expansion, without the account-management lift that the horizontal SaaS land-and-expand model usually demands. Once a platform already retains a buyer's full compliance footprint, expanding into the next adjacent workflow feels like closing a low-friction loop rather than kicking off another sales pitch that demands a fresh, hard-fought close.

Veeva's trajectory inside life sciences shows the mechanism running at full scale. By fiscal 2026, Veeva eTMF was in place at all of the biggest biopharma companies, QualityDocs at nearly all of them, and Submissions at 18 among the top 20. That is growth spreading across neighboring compliance workflows within one and the same set of customers, with no push beyond into fresh verticals. Vault Submissions Publishing sends filings straight to the FDA, to the EMA, and to regulators elsewhere via gateway connections, which places the platform inside the approval workflow itself. Once a customer's filings already travel through that connection, adopting another Veeva product becomes the default path rather than a prize contested in a head-to-head evaluation.

nCino makes the same point by a different route, namely the model it runs through partners. Veeva settled its earlier IQVIA disputes in fiscal 2026 and then struck a lasting partnership, and the effect is identical: clients can draw on both firms' tools, datasets, platforms, and services together, widening the set of compliance surfaces Veeva oversees rather than forcing Veeva to construct each one on its own.

These patterns show that regulatory moats work differently than network effects. Unlike network-driven advantages, this kind of barrier cannot scale with adoption, since every regulated vertical inherently limits its own customer pool. Veeva's agentic AI extends that idea even further. By embedding specialized agents spanning every major life sciences function into the Vault Platform, Veeva AI lets the firm monetize current compliance records without acquiring any additional customers.

The real ceiling: when regulation becomes a market-size constraint rather than a moat

Compliance moats stop being persuasive when the addressable market is too shallow, even if the position itself is defensible. The best regulated markets combine a broad customer base with heavy compliance demands so domestic ARR can become material, and many regulated niches still fall short. A company may lock down compliance in a niche with too little revenue potential, ending up protected but unable to scale.

As 2026 approaches, the most promising verticals must answer one question: can home-market revenue hit an ARR of about one hundred million dollars before global expansion becomes necessary? A lot of regulated niches never hit that mark, regardless of how deep their compliance obligations go. Because any single regulated sector contains only a limited pool of purchasers, dominating several hundred enterprise clients creates formidable defenses over a narrow compounding surface. That makes the network effect argument far thinner here than it is in horizontal software.

The moat only matters if the company has gone deep. If a vertical SaaS vendor has only shallow adoption in its market, it has not yet created the lock-in enjoyed by a rival that dominates the same niche. For platforms already embedded that deeply, agentic AI lifts part of the ceiling. The chosen vertical determines if the compliance layer added above it can become a scalable business or merely a survivor.

The Playbook in Practice: Decisions in Sequence

A compliance-led GTM playbook unfolds step by step, not as parallel tracks the team tackles all at once. Which buyers count as ICP is set by vertical selection. The ICP then governs the sales motion capable of actually closing deals. And the sales motion determines the pricing model buyers will tolerate. The origin of expansion revenue depends on pricing structure, while Compliance architecture binds each element of that sequence. Omitting a single phase yields a GTM motion appearing sound on slides yet collapsing during execution.

Start by choosing a regulated sector whose compliance demands and buyer base are substantial enough to support real scale. Assess if local demand can carry the target ARR for the first several years before the company must expand internationally.

Second, ICP functions as a screen for compliance preparedness. A prospect who has invested substantially in workaround configurations arrives already qualified, unlike one who has yet to experience that pain.

Third, make trust architecture the organizing principle for the sales motion. Approach initial adopters as the place to establish credibility deliberately rather than extract the most revenue, since concentrated referrals there give the wider motion its scale.

The fourth decision is to make partners part of the compliance foundation. Partners win early trust from the buyer’s risk and compliance reviewers in the platform’s regulatory position, reducing procurement time before sales gets involved.

Fifth, choose the pricing structure. Design pricing that grows with the buyer’s regulatory burden, whether tied to assets, usage, or results, so expansion is driven by the buyer’s growth.

Once a platform saturates its niche, the final move is to stack autonomous AI and partner networks atop the regulatory groundwork it already owns. This turns the growth-cap critique from a theoretical worry into a solved problem, since upsell income stops depending on fresh customer acquisition and instead leverages hard-won regulatory standing.